The Defense Logistics Agency (DLA) awarded a $3,561.86 firm fixed-price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The delivery order is for the pharmaceutical product Stelara 45 mg/0.5 ml syringe and is not associated with a set-aside designation. DMS Pharmaceutical Group Inc. holds a larger $499,999,999 Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, which enables the agency to issue delivery orders for a wide range of branded and generic prescription drugs, over-the-counter medications, biologics, and medical consumables to support the medical supply needs of military health facilities worldwide. This contract award demonstrates DMS Pharmaceutical Group's capability to provide specialized pharmaceutical products to the Department of Defense through its participation in the federal supply chain.
Generated 1/16/25, 9:08 AM